MicroVision Announces Fourth Quarter and Full-Year 2025 Results: Strategic Acquisitions, Restructuring, and Financial Position

Key Highlights and Developments

• Strategic Commercial Momentum: MicroVision advanced its commercial efforts in the Industrial and Security & Defense sectors, initiating shipments in December 2025 on repeatable orders for MOVIA L sensors featuring integrated software.
• Expansion in Europe: The company began the early integration of a new team in southern Germany, focusing on developing a frequency-modulated continuous wave (FMCW) ultra-long-range lidar sensor following the acquisition of assets from Scantinel Photonics GmbH.
• Major Acquisition: MicroVision set the stage for the early 2026 closing of a significant strategic acquisition of lidar business assets from Luminar Technologies, Inc. This acquisition is expected to accelerate immediate revenue opportunities, diversify the product portfolio, and bring in new customer engagements.
• Operational Restructuring: Post-acquisition, MicroVision announced plans to reduce its global workforce by approximately 20% in the first half of 2026. The company will consolidate engineering and operations from Redmond to its Orlando location, aiming to streamline expenses.
• Strengthened Balance Sheet: In February 2026, MicroVision issued two senior secured convertible notes totaling approximately \$43 million (\$20.6 million exchanged for an existing note and \$22.4 million in new notes) to bolster liquidity and extend debt maturities to March 2028.

Management Commentary

CEO Glen DeVos highlighted that MicroVision’s preparation in late 2025 enabled a strong start to 2026. He emphasized the company’s transition from an R&D-focused business to a commercially driven enterprise, with initial shipments on recurring orders and the completion of two strategic asset acquisitions (Luminar and Scantinel). These moves have diversified MicroVision’s portfolio and enhanced its cash position.

DeVos reinforced the company’s commitment to “redefining the lidar industry” with performance-driven, cost-effective solutions for automotive, industrial, and security & defense customers. He described the current phase as “Lidar 2.0,” with MicroVision positioned to lead this new era.

Financial Highlights

• Q4 2025 Revenue: \$0.2 million, a steep decline from \$1.7 million in Q4 2024.
• Q4 2025 Net Loss: \$37.8 million (\$0.12 per share), which included \$29.4 million in non-cash charges (mainly asset impairment and inventory write-downs), partially offset by \$1.5 million in share-based compensation credits. This compared to a Q4 2024 net loss of \$31.2 million (\$0.14 per share).
• Adjusted EBITDA: Loss of \$12.0 million in Q4 2025 versus a \$10.6 million loss in Q4 2024.
• Cash Used in Operations: \$15.4 million in Q4 2025 versus \$15.1 million in Q4 2024.
• Year-End Liquidity: \$74.8 million in cash and cash equivalents, including investment securities, virtually unchanged from \$74.7 million at the end of 2024.
• Convertible Notes: \$43 million in new senior secured convertible notes issued after Q4, improving liquidity and deferring near-term debt obligations.
• ATM Facility: \$43 million of capacity remains under the company’s at-the-market (ATM) facility, subject to market conditions.

Detailed Financial Performance

Income Statement

• Full-Year 2025 Revenue: \$1.2 million, down from \$4.7 million in 2024.
• Full-Year Net Loss: \$95.0 million (\$0.35 per share), slightly improved from a \$96.9 million loss in 2024 (\$0.46 per share).
• Operating Expenses: \$65.5 million in 2025, down from \$82.7 million in 2024, due to lower R&D and SG&A but higher impairment charges.
• Gross Loss: \$(17.3) million in 2025, compared to \$(2.8) million in 2024. High cost of revenue and inventory write-downs contributed to this deterioration.
• Impairment Losses: Significant non-cash impairments in 2025 included \$10.1 million on intangible assets, \$1.2 million on operating lease assets, and \$2.2 million on property and equipment.

Balance Sheet

• Total Assets: \$103.1 million as of December 31, 2025, down from \$121.2 million in 2024.
• Cash and Investment Securities: \$74.8 million at year-end 2025.
• Total Liabilities: \$47.6 million, improved from \$72.4 million in 2024 due to reductions in derivative liabilities and current notes payable.
• Shareholders’ Equity: \$55.5 million, up from \$48.8 million in 2024, reflecting new capital raised despite ongoing losses.

Cash Flow

• Net Cash Used in Operations: \$58.7 million in 2025, improved from \$68.5 million in 2024.
• Investing Activities: \$(24.6) million, largely due to purchases of investment securities and payments related to the Scantinel advance.
• Financing Activities: \$60.9 million net cash provided, driven by \$77.4 million from equity issuance and \$16.5 million in note repayments.
• Year-End Cash Position: \$34.1 million in cash, cash equivalents, and restricted cash.

Non-GAAP Measures

• Adjusted EBITDA (2025): \$(45.6) million, compared to \$(53.5) million in 2024, showing improvement despite ongoing losses.
• Adjusted Gross Profit (2025): \$(0.5) million, down from a positive \$1.4 million in 2024.

Non-GAAP measures exclude significant non-cash expenses, share-based compensation, restructuring costs, and impairment charges, offering a clearer view of operating performance.

Strategic and Shareholder-Relevant Developments

• Business Model Transformation: MicroVision is transitioning from R&D to commercialization, now shipping products on repeatable orders and integrating acquired assets.
• Acquisitions: The Luminar and Scantinel asset acquisitions position MicroVision as a more diversified player with increased revenue opportunities and a deeper technology portfolio. These moves can be significant catalysts for future revenue and share price appreciation if integration is successful.
• Cost Controls: The planned 20% reduction in global workforce and site consolidation is expected to reduce operating expenses, supporting the path to profitability.
• Financial Flexibility: The new convertible notes and ATM facility provide additional liquidity, though dilution risk exists for shareholders if equity is issued at lower prices.
• Risks: The company continues to operate at a loss with high cash burn, though the balance sheet remains relatively stable following new capital raises. Execution risks around acquisitions, integration, and market adoption remain substantial. Impairment charges and inventory write-downs highlight ongoing challenges in monetizing technology and inventory.

Potential Price-Sensitive Implications for Shareholders

• Major Acquisitions: Success or failure in integrating the Luminar and Scantinel assets could have a material impact on future revenue growth and profitability, directly affecting share value.
• Operational Restructuring: Workforce reductions and site consolidation may lead to near-term cost savings but could also indicate ongoing operational challenges.
• Liquidity and Debt: The new convertible notes extend debt maturities, enhancing financial stability, but may introduce future dilution if shares are used for redemptions.
• Continued Losses: Persistent net losses and negative cash flow highlight the need for successful execution of the new commercial strategy to improve financial results and support the share price.
• Revenue Decline: The sharp drop in revenue and increase in cost of revenue, leading to gross losses, is a negative indicator and may weigh on investor sentiment until new revenue streams materialize.

Conference Call Information

MicroVision will host a conference call and webcast with management commentary and Q&A at 1:30 PM PT/4:30 PM ET on March 4, 2026. Investors can access the webcast on the company’s Investor Relations website.

About MicroVision

MicroVision provides lidar-based perception solutions for automotive, industrial, and security & defense markets, with engineering centers in the U.S. and Germany. The company prides itself on its broad portfolio of short- and long-range solid-state lidar sensors and open software solutions.

Disclaimer

This article contains forward-looking statements based on MicroVision’s recent financial disclosures, planned acquisitions, and operational restructuring. Actual results may differ materially due to a variety of risks, including integration risks, market adoption, and ongoing operating losses. Investors should review all company filings and consult their financial advisors before making investment decisions. The information provided herein is for informational purposes only and does not constitute investment advice.

View MICROVISION, INC. Historical chart here